Back

Mortality and heart failure in patients with severe tricuspid regurgitation. Impact of RV volumes and function by CMR.

30 August 2024 (12:00 - 12:50)
Organised by: Logo
Congress Presentation Part of: Mechanisms and staging of tricuspid regurgitation Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mrs Rocio Hinojar Baydes

Ramon and Cajal University Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
A new right-heart failure staging system in patients with severe tricuspid regurgitation. Prognostic implications.
Doctor J. Gomez Polo (Madrid, ES) Doctor P. Mahia (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Tricuspid regurgitation in the context of severe concomitant left-sided valvular heart disease: patients characteristics and long-term clinical and interventional outcomes
Doctor D. Margonato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation on progression of tricuspid regurgitation in patients undergoing transcatheter aortic valve replacement
Doctor T. Yoshida (Kawasaki, JP)
Abstract Slides Video
Presentation thumbnail
Predictors of progression to significant atrial functional tricuspid regurgitation in patients with paroxysmal or persistent atrial fibrillation
Assistant Professor S. Song (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Assessment of right ventricular function in patients with severe secondary tricuspid regurgitation, following to the TVARC recommendations: association with outcome
Mr X. Galloo (Brussels, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms and staging of tricuspid regurgitation

The Event

Event poster

ESC Congress 2024

30 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Does adjusting of RVEF for tricuspid regurgitation improve prognosis of RV dysfunction in heart failure?
thumbnail
Congress Presentation
Refining tricuspid regurgitation grading: do mild-to-moderate and moderate-to-severe categories improve mortality prediction in heart failure patients?
thumbnail
Congress Presentation
The impact of baseline right heart size and function on heart failure hospitalization and mortality: 2-year results of the TRILUMINATE Trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources